Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,332 total articles
Pyxis Oncology reported its Q2 2026 financial results and highlighted progress in its MICVO clinical programs targeting recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). The company completed a private placement raising approximately $50 million upfront, extending its cash runway into Q2 2027. Updated data from Phase 1 monothe…
Zenas BioPharma announced FDA acceptance of its Biologics License Application (BLA) for obexelimab treating IgG4-Related Disease, with a PDUFA target action date of May 27, 2027. The company confirmed bioequivalence of obexelimab delivery methods, plans a European submission, and expects Phase 2 topline data for Systemic Lupus Erythematosus in Q4 2…
Chicago Atlantic BDC, Inc. reported its second quarter 2026 financial results, highlighting a stable portfolio with no non-accrual loans and a weighted average yield of 16.0% on debt investments. The company ended the quarter with $73.9 million in liquidity and a $1.1 billion pipeline. It declared a third quarter dividend of $0.34 per share. Additi…
MediWound Ltd. reported second quarter 2026 financial results, highlighting progress in its EscharEx® Phase III VALUE trial targeting chronic wounds and a strengthened commercial agreement with Vericel under a BARDA contract for its burn treatment product NexoBrid®. Revenue for Q2 2026 was $3.1 million, with full-year guidance reaffirmed at $24-26 …
FactSet has announced a quarterly cash dividend of $1.16 per share, payable on September 17, 2026, to shareholders of record as of August 31, 2026. The company continues to demonstrate commitment to delivering value to shareholders amid its ongoing provision of financial intelligence and AI solutions globally.
Olema Pharmaceuticals, a clinical-stage biopharmaceutical company focused on breast cancer therapies, announced the appointment of Jason O’Byrne as Chief Financial Officer. With a strong background in biotech finance and operations, O’Byrne will support Olema as it approaches key clinical data readouts and prepares for its initial commercial launch…
YXT.com Group Holding Limited reported a 6% revenue increase to RMB162.1 million (US$23.9 million) for the first half of 2026 compared to the previous year. The company achieved a higher gross margin of 70.1% and significantly reduced its net loss by over 80% to RMB14.4 million (US$2.1 million). Growth is attributed to AI-native transformation and …
Aveanna Healthcare Holdings Inc. announced strong financial results for Q2 2026, with revenue increasing 13.7% year-over-year to $670.5 million and adjusted EBITDA rising 8.0% to $95.4 million. The company raised its full-year 2026 revenue guidance to over $2.68 billion and adjusted EBITDA guidance to over $365 million, citing strong performance ac…
Nutriband Inc.'s CEO Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit focusing on the company's AVERSA™ abuse-deterrent transdermal technology designed to prevent abuse and accidental exposure of drugs like fentanyl. The technology is covered by broad international patents and aims to improve safety profiles of transdermal drug…
Tilray Brands' Montauk Brewing Company announced a partnership with Morning Brew Inc. to release The Morning Brew, a limited-edition light blonde ale. This collaboration enhances Montauk Brewing’s brand presence and leverages Morning Brew’s media influence, with plans for ongoing promotional activities leading up to the 2026 New York City Marathon.
Aebi Schmidt Group reported a 22% increase in adjusted EBITDA and a 16% growth in order intake for Q2 2026 compared to Q2 2025, alongside a 9% rise in net sales. The company attributes its improved profitability to operational improvements and an expanded market footprint, with strong performance in North America and Europe. Net income turned posit…
ProQR Therapeutics reported positive Phase 1 target engagement data for AX-0810, marking the first clinical validation of its proprietary Axiomer RNA editing platform targeting NTCP modulation for cholestatic diseases. The company outlined a robust pipeline with upcoming clinical milestones including Phase 1 data for AX-0811, initiation of biliary …
Legence Corp. reported strong second quarter 2026 financial results with record revenues of $1.26 billion, a 111% increase year-over-year, driven by solid organic growth and the Bowers acquisition. Adjusted EBITDA more than doubled to $154.6 million. The company also reported record backlog and awarded contracts totaling $5.67 billion, a 105% incre…
The Scotts Miracle-Gro Company is collaborating with America250 to bring the 'Our American Story' Airstream mobile studio to ScottsMiracle-Gro Field in Columbus, Ohio, as part of the nation's 250th anniversary celebrations. The initiative aims to collect oral and visual histories that highlight Ohio's cultural and historical influence in America. T…
LENSAR, Inc. reported its second quarter 2026 financial results, highlighting an 18% increase in total revenue and a 20% growth in recurring revenue compared to the same period last year. The company placed 10 new ALLY Robotic Cataract Laser Systems during the quarter, increasing the installed base to 445 systems. Net income turned positive at $3.5…
Parabilis Medicines reported progress in its clinical programs, especially zolucatetide—an investigational direct inhibitor targeting the β-catenin:TCF interaction in multiple Wnt/β-catenin-driven diseases. The company plans to initiate a Phase 3 registrational trial for desmoid tumors in early 2027. Parabilis also announced a major collaboration w…
Victoria's Secret & Co. (NYSE: VSXY) announces its second quarter 2026 earnings release and invites investors and analysts to participate in a live webcast conference call scheduled for September 3, 2026. The company provides details about accessing the webcast and highlights its business segments, including Victoria's Secret, PINK, and Adore Me. A…
Chicago Atlantic BDC, Inc., a NASDAQ-listed specialty finance company focusing on direct loans primarily to privately held middle-market companies in the cannabis sector, announced a quarterly cash dividend of $0.34 per share for Q3 2026. The dividend record date is September 25, 2026, with payment on October 9, 2026. The company emphasizes maximiz…
Brookfield Wealth Solutions announced strong second quarter 2026 results, highlighted by a significant increase in total assets surpassing $200 billion, driven by the successful acquisition and integration of Just Group plc. The company reported distributable operating earnings growth and expanded international operations, with substantial annuity …
Bending Spoons announced Q2 2026 financial results showing a 126% increase in revenue to $704 million and a 139% rise in operating income to $240 million compared to Q2 2025. Diluted EPS increased 163% to $0.28. The company completed an IPO on Nasdaq under symbol BSP, raising $1.10 billion. It acquired Tractive and entered an agreement to acquire A…
Dillard's, Inc. announced a 1% increase in total retail sales and a significant rise in net income to $97.7 million for Q2 2026 compared to the prior year. The company's retail gross margin improved due to tariff refunds and a favorable litigation settlement related to payment card interchange fees. Operating expenses rose slightly due to higher pa…
Titan Machinery Inc. plans to release its financial results for the fiscal second quarter ended July 31, 2026, on August 27, 2026, followed by a live investor conference call. The company operates a large network of agricultural and construction equipment dealerships across North America, Europe, and Australia, representing CNH Industrial Brands.
Bullish, a digital asset platform listed on the NYSE, reported its Q2 2026 financial results highlighting $92.6 million in adjusted revenue (up 62% year-over-year) driven by record subscription and services revenue. Despite a net loss of $280 million on a $32.6 billion digital asset sales volume (down from $58.6 billion), the company improved adjus…
Brookfield Corporation announced a 15% increase in earnings per share for Q2 2026, supported by record fundraising of $98 billion, the acquisition of Oaktree and Just Group, and continued asset monetization. The company reported $210 billion in deployable capital, underscoring its strong liquidity and capacity to invest in large-scale opportunities…
Golar LNG Limited announced robust financial results for Q2 2026, including a 145% increase in net income attributable to the company, and significant operational progress such as signing an EPC contract for its 4th FLNG unit with a cost of approximately $2.45 billion. The company maintains a strong liquidity position with $908 million cash and sec…
